Cargando…
MON-189 Glycemic Control and the Presence of Complications in Glycogen Storage Disease Type I: Results from the Swiss Registry
Background: Regular carbohydrate intake to avoid hypoglycemia is the mainstay of dietary treatment in glycogen storage disease type I (GSDI). The aim of this study was to evaluate the quality of dietary treatment and glycemic control in a cohort of GSDI patients, in relation to the presence of typic...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551045/ http://dx.doi.org/10.1210/js.2019-MON-189 |
_version_ | 1783424321655406592 |
---|---|
author | Kaiser, Nathalie Gautschi, Matthias Bosanska, Lenka Meienberg, Fabian Baumgartner, Matthias Spinas, Giatgen Hochuli, Michel |
author_facet | Kaiser, Nathalie Gautschi, Matthias Bosanska, Lenka Meienberg, Fabian Baumgartner, Matthias Spinas, Giatgen Hochuli, Michel |
author_sort | Kaiser, Nathalie |
collection | PubMed |
description | Background: Regular carbohydrate intake to avoid hypoglycemia is the mainstay of dietary treatment in glycogen storage disease type I (GSDI). The aim of this study was to evaluate the quality of dietary treatment and glycemic control in a cohort of GSDI patients, in relation to the presence of typical long-term complications. Methods: Data of 25 patients (22 GSD subtype Ia and 3 GSDIb, median age 20y) from the Swiss hepatic glycogen storage disease registry was analyzed cross-sectionally. Frequency and type of hypoglycemia symptoms were assessed prospectively using a structured questionnaire. Continuous glucose monitoring (CGMS) was performed as part of usual clinical care to assess glycemic control in 14 patients. Results: Although maintenance of euglycemia is the primary goal of dietary treatment, few patients (n=3, 13%) performed capillary blood glucose measurements regularly. Symptoms of hypoglycemia were present in 13 patients (57 %), but CGMS revealed periods of low glucose (<4mmol/l) in all patients, irrespective of the presence of symptoms. GSDIa patients with liver adenomas (n=9, 41%) showed a higher frequency and area under the curve (AUC) of low blood glucose than patients without adenomas (frequency 2.7±0.8 vs. 1.5±0.7 per day, AUC 0.11±0.08 vs. 0.03±0.02 mmol/l/d, p<0.05). The presence of microalbuminuria was also related to the frequency of low blood glucose. Z-Scores of bone density correlated negatively with lactate levels. Conclusion: The quality of glucose control is related to the presence of typical long-term complications in GSDI. Many patients experience episodes of asymptomatic low blood glucose. Regular assessment of glucose control is an essential element to evaluate the quality of treatment, and increasing the frequency of glucose self-monitoring remains an important goal of patient education and motivation. CGMS devices may support patients to optimize dietary therapy in everyday life. |
format | Online Article Text |
id | pubmed-6551045 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Endocrine Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-65510452019-06-13 MON-189 Glycemic Control and the Presence of Complications in Glycogen Storage Disease Type I: Results from the Swiss Registry Kaiser, Nathalie Gautschi, Matthias Bosanska, Lenka Meienberg, Fabian Baumgartner, Matthias Spinas, Giatgen Hochuli, Michel J Endocr Soc Diabetes Mellitus and Glucose Metabolism Background: Regular carbohydrate intake to avoid hypoglycemia is the mainstay of dietary treatment in glycogen storage disease type I (GSDI). The aim of this study was to evaluate the quality of dietary treatment and glycemic control in a cohort of GSDI patients, in relation to the presence of typical long-term complications. Methods: Data of 25 patients (22 GSD subtype Ia and 3 GSDIb, median age 20y) from the Swiss hepatic glycogen storage disease registry was analyzed cross-sectionally. Frequency and type of hypoglycemia symptoms were assessed prospectively using a structured questionnaire. Continuous glucose monitoring (CGMS) was performed as part of usual clinical care to assess glycemic control in 14 patients. Results: Although maintenance of euglycemia is the primary goal of dietary treatment, few patients (n=3, 13%) performed capillary blood glucose measurements regularly. Symptoms of hypoglycemia were present in 13 patients (57 %), but CGMS revealed periods of low glucose (<4mmol/l) in all patients, irrespective of the presence of symptoms. GSDIa patients with liver adenomas (n=9, 41%) showed a higher frequency and area under the curve (AUC) of low blood glucose than patients without adenomas (frequency 2.7±0.8 vs. 1.5±0.7 per day, AUC 0.11±0.08 vs. 0.03±0.02 mmol/l/d, p<0.05). The presence of microalbuminuria was also related to the frequency of low blood glucose. Z-Scores of bone density correlated negatively with lactate levels. Conclusion: The quality of glucose control is related to the presence of typical long-term complications in GSDI. Many patients experience episodes of asymptomatic low blood glucose. Regular assessment of glucose control is an essential element to evaluate the quality of treatment, and increasing the frequency of glucose self-monitoring remains an important goal of patient education and motivation. CGMS devices may support patients to optimize dietary therapy in everyday life. Endocrine Society 2019-04-30 /pmc/articles/PMC6551045/ http://dx.doi.org/10.1210/js.2019-MON-189 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Diabetes Mellitus and Glucose Metabolism Kaiser, Nathalie Gautschi, Matthias Bosanska, Lenka Meienberg, Fabian Baumgartner, Matthias Spinas, Giatgen Hochuli, Michel MON-189 Glycemic Control and the Presence of Complications in Glycogen Storage Disease Type I: Results from the Swiss Registry |
title | MON-189 Glycemic Control and the Presence of Complications in Glycogen Storage Disease Type I: Results from the Swiss Registry |
title_full | MON-189 Glycemic Control and the Presence of Complications in Glycogen Storage Disease Type I: Results from the Swiss Registry |
title_fullStr | MON-189 Glycemic Control and the Presence of Complications in Glycogen Storage Disease Type I: Results from the Swiss Registry |
title_full_unstemmed | MON-189 Glycemic Control and the Presence of Complications in Glycogen Storage Disease Type I: Results from the Swiss Registry |
title_short | MON-189 Glycemic Control and the Presence of Complications in Glycogen Storage Disease Type I: Results from the Swiss Registry |
title_sort | mon-189 glycemic control and the presence of complications in glycogen storage disease type i: results from the swiss registry |
topic | Diabetes Mellitus and Glucose Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551045/ http://dx.doi.org/10.1210/js.2019-MON-189 |
work_keys_str_mv | AT kaisernathalie mon189glycemiccontrolandthepresenceofcomplicationsinglycogenstoragediseasetypeiresultsfromtheswissregistry AT gautschimatthias mon189glycemiccontrolandthepresenceofcomplicationsinglycogenstoragediseasetypeiresultsfromtheswissregistry AT bosanskalenka mon189glycemiccontrolandthepresenceofcomplicationsinglycogenstoragediseasetypeiresultsfromtheswissregistry AT meienbergfabian mon189glycemiccontrolandthepresenceofcomplicationsinglycogenstoragediseasetypeiresultsfromtheswissregistry AT baumgartnermatthias mon189glycemiccontrolandthepresenceofcomplicationsinglycogenstoragediseasetypeiresultsfromtheswissregistry AT spinasgiatgen mon189glycemiccontrolandthepresenceofcomplicationsinglycogenstoragediseasetypeiresultsfromtheswissregistry AT hochulimichel mon189glycemiccontrolandthepresenceofcomplicationsinglycogenstoragediseasetypeiresultsfromtheswissregistry |